Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (6) , 823-834
Abstract
XueBiJing, an injectable five-herb preparation, has been incorporated into routine sepsis care in China. Phthalides, originating from XueBiJing9s component herbs Ligusticum chuanxiong rhizomes and Angelica sinensis roots, are believed to contribute to its therapeutic effects due to their presence in the preparation and antisepsis-related properties. This study aimed to identify potential therapeutic phthalides that are bioavailable to act on XueBiJing9s therapeutic targets and that could serve as pharmacokinetic markers to supplement classical biomarkers for sepsis care. Among 10 phthalides detected in XueBiJing, senkyunolides I and G were the major circulating phthalides in human subjects, but their different pharmacokinetics might influence their contribution to XueBiJing9s therapeutic action. Senkyunolide I exhibited a large distribution volume (1.32 l/kg) and was moderately bound in plasma (54% unbound), whereas senkyunolide G exhibited a small distribution volume (0.10 l/kg) and was extensively bound in plasma (3% unbound). Clearance of senkyunolide I from the systemic circulation was governed by UGT2B15-mediated hepatic glucuronidation; the resulting electrophilic glucuronides were conjugated with GSH in the liver. Senkyunolide G was selectively bound to albumin (99%) in human plasma. To our knowledge, the human pharmacokinetic data of XueBiJing9s phthalides are reported here for the first time. Based on this study and such studies for the other component herbs, follow-up pharmacodynamic assessments of bioavailable herbal compounds are planned to understand XueBiJing9s chemical basis responsible for its therapeutic action. Senkyunolides I and G, having the preceding disposition characteristics that could be detectably altered by septic pathophysiology, could serve as pharmacokinetic markers for sepsis care.Keywords
This publication has 36 references indexed in Scilit:
- A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart FailureJACC, 2013
- Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administrationBritish Journal of Pharmacology, 2013
- Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical TrialEvidence-Based Complementary and Alternative Medicine, 2013
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 InfluenzaAnnals of Internal Medicine, 2011
- Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microgliaNeuropharmacology, 2011
- Identification of the major constituents in Xuebijing injection by HPLC‐ESI‐MSPhytochemical Analysis, 2011
- Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1Chemico-Biological Interactions, 2010
- Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to RatsDrug Metabolism and Disposition, 2009
- Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu-tang across human intestinal Caco-2 cell monolayers1Acta Pharmacologica Sinica, 2008
- UDP Glucuronosyltransferase mRNA Levels in Human Liver DiseaseDrug Metabolism and Disposition, 2002